Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGPAT2 | O15120 | 11/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | TP53 | P04637 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.48 |
| ▸ | CASP3 | P42574 | 1/20 | 0.48 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.48 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.48 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.45 |
| ▸ | CASP7 | P55210 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25997472 | 0.85 | HPSE (0.49) | AGPAT2KDM4ETP53SMN1; SMN2NPC1 | |
| SCHEMBL17445542 | 0.81 | CYP19A1 (0.65) | KDM4ETP53SMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL31018099 | 0.81 | CYP19A1 (0.65) | KDM4ETP53SMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL31018098 | 0.81 | CYP19A1 (0.65) | KDM4ETP53SMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL26972221 | 0.81 | MEN1 (0.46) | AGPAT2KDM4ETP53SMN1; SMN2NPC1 | |
| SCHEMBL11370585 | 0.79 | PTPN1 (0.62) | KDM4ETP53ALDH1A1HPGDMAPT | |
| SCHEMBL26050351 | 0.75 | KDM4E (0.74) | KDM4ETP53SMN1; SMN2NPC1ALDH1A1 | |
| SCHEMBL22371423 | 0.75 | ELANE (0.45) | AGPAT2TP53RAB9AMAPTPOLB | |
| SCHEMBL31135851 | 0.75 | ELANE (0.45) | AGPAT2TP53RAB9AMAPTPOLB | |
| SCHEMBL25997345 | 0.74 | AGPAT2 (0.53) | AGPAT2KDM4ETP53SMN1; SMN2NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230383342-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID SEQUENCING | ILLUMINA, INC. | 2023-11-30 | — | — | US | disclosed |
| US-20230304086-A1 | LABELED AVIDIN AND METHODS FOR SEQUENCING | ILLUMINA CAMBRIDGE LIMITED (GB) | 2023-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230304086-A1 | LABELED AVIDIN AND METHODS FOR SEQUENCING | ANXA6, ANXA3, BCDIN3D | AGPAT2 2512/4885KDM4E 4248/4885TP53 1536/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.